6Lun·

Fast Track is being discussed for Anktiva in lung cancer. Now it's all happening fast.

attachment

$IBRX (+1,97 %)

7
3 Comentarios

Imagen de perfil
Just don't forget to take profits and sell off the hype before everyone else does with small biotech bets 💪🏼
1
Imagen de perfil
I intend to hold on for the long term. $IBRX is about to make history - in my opinion.
Mostrar respuesta
Únase a la conversación